A rare case of ALECT-2-amyloidosis with kidney damage
https://doi.org/10.21886/2712-8156-2025-6-2-87-92
Abstract
A clinical case of the rare kidney disease ALECT-2-amyloidosis, which is the first description of this pathology in the Russian Federation, is presented. The data of patient D., 72 years old, who sought medical help in December 2024 with complaints of severe general weakness, shortness of breath, lack of appetite, and widespread edema are presented. There were signs of nephrotic syndrome. A morphological examination of the kidney biopsy revealed a pattern of amyloidosis with a predominant lesion of the arterial walls, arterioles, and glomeruli. At the same time, the deposits were identified as not belonging to the AA-type and AL-type using immunofluorescence analysis using appropriate antibodies. Proteomic analysis of urine revealed an increase in the level of leukocyte chemotoxic factor 2 (LECT2), which indicates its relation to amyloidogenesis. At the same time, in the cases described in the literature, as a rule, there was no increase in its plasma level, which was also not recorded during a proteomic blood test in our patient. Thus, amyloidosis with kidney damage was caused in the patient by LECT2 and was identified as LECT2-amyloidosis.
About the Authors
M. M. BatyushinRussian Federation
Mikhail M. Batiushin, Professor, Dr. Sci. (Med.), Professor of the Department of Internal Diseases No. 2
Rostov-on-Don
L. R. Ablyakimova
Russian Federation
Lera R. Ablyakimova, nephrologist
Bataysk
R. A. Gurtskoy
Russian Federation
Roman A. Gurtskoy, Professor, Dr. Sci. (Med.), Head of the Road Center of Urology, Nephrology and Andrology
Bataysk
E. V. Semenenko
Russian Federation
Ekaterina V. Semenenko, pulmonologist of the highest category, head of the therapeutic department
Bataysk
P. E. Povilaityte
Russian Federation
Patricia E. Povilaite, Cand. Sci. (Bio.), Head of the Laboratory
Rostov-on-Don
I. V. Sarvilina
Russian Federation
Irina V. Sarvilina, Professor, Dr. Sci. (Med.), Director
Rostov-on-Don
References
1. Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B. Leukocyte chemotactic factor 2: A novel renal amyloid protein. Kidney Int. 2008;74(2):218-222. https://doi.org/10.1038/ki.2008.152
2. Larsen CP, Walker PD, Weiss DT, Solomon A. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int. 2010;77(9):816-819. https://doi.org/10.1038/ki.2010.9
3. Murphy CL, Wang S, Kestler D, Larsen C, Benson D, Weiss DT, Solomon A. Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series. Am J Kidney Dis. 2010;56(6):1100-1107. https://doi.org/10.1053/j.ajkd.2010.08.013
4. Xu H, Jia Y, Wang X, Wang H, Yu J, Hao W. Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: A case report. Medicine (Baltimore). 2022;101(29):e29638. https://doi.org/10.1097/MD.0000000000029638
5. Xu J, Wang X, Weng Q, Feng X, Pan X. First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis. BMC Nephrol. 2023;24(1):283. https://doi.org/10.1186/s12882-023-03331-x
6. Wang Y, Wang SX, Zhang YK. [Leukocyte chemotactic factor 2 associated renal amyloidosis: one case report]. Beijing Da Xue Xue Bao Yi Xue Ban. 2015;47(2):349-351. (In Chinese). PMID: 25882959.
7. Zhu MH, Liu YJ, Li CY, Tao F, Yang GJ, Chen J. The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential. Front Immunol. 2023;14:1158083. https://doi.org/10.3389/fimmu.2023.1158083
8. Hiraki Y, Inoue H, Kondo J, Kamizono A, Yoshitake Y, Shukunami C, Suzuki F. A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II. Purification and amino acid sequence. J Biol Chem. 1996;271(37):22657-22662. https://doi.org/10.1074/jbc.271.37.22657
Supplementary files
Review
For citations:
Batyushin M.M., Ablyakimova L.R., Gurtskoy R.A., Semenenko E.V., Povilaityte P.E., Sarvilina I.V. A rare case of ALECT-2-amyloidosis with kidney damage. South Russian Journal of Therapeutic Practice. 2025;6(2):87-92. (In Russ.) https://doi.org/10.21886/2712-8156-2025-6-2-87-92